You are here
M. D. Anderson - Leukemia Insights Newsletter Volume 13, No. 2 Fall 2008
M. D. Anderson
D. Anderson
Leukemia Insights Newsletter
Updates Of New Strategies in Chronic Myelogenous Leukemia (CML)
In this Issue:
# Introduction
# Imatinib
# Management of Myelosuppression
# New Tyrosine Kinase Inhibitors & Other Agents to Treat CML Post Imatinib Failure
# Nilotinib
# Dasatinib
# Bosutinib (SKI-606)
# T315I Inhibitors
# Homoharringtonine (HHT)
# Immune Modulation
# Monitoring Response & Resistance to Therapy in CML
# References